Variant report
Variant | esv3517354 |
---|---|
Chromosome Location | chr7:6911027-6924325 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:67)
- CpG islands (count:611)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr7:6911459-6911623 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr7:6911365-6911638 | GM12878 | blood: | n/a | n/a |
3 | BCL3 | chr7:6916434-6916785 | GM12878 | blood: | n/a | n/a |
4 | CEBPB | chr7:6914862-6914979 | K562 | blood: | n/a | n/a |
5 | CEBPB | chr7:6912527-6912646 | HepG2 | liver: | n/a | n/a |
6 | CTCF | chr7:6911509-6911662 | GM19240 | blood: | n/a | n/a |
7 | CTCF | chr7:6911487-6911673 | K562 | blood: | n/a | n/a |
8 | CTCF | chr7:6911494-6911676 | GM19238 | blood: | n/a | n/a |
9 | CTCF | chr7:6911606-6911624 | GM10248 | blood: | n/a | n/a |
10 | CTCF | chr7:6911545-6911700 | GM12878 | blood: | n/a | n/a |
11 | CTCF | chr7:6911533-6911657 | MCF-7 | breast: | n/a | n/a |
12 | CTCF | chr7:6911056-6911130 | GM20000 | blood: | n/a | n/a |
13 | CTCF | chr7:6911541-6911662 | NHEK | skin: | n/a | n/a |
14 | CTCF | chr7:6911740-6911890 | GM12873 | blood: | n/a | n/a |
15 | CTCF | chr7:6911495-6911696 | GM12878 | blood: | n/a | n/a |
16 | CTCF | chr7:6911564-6911634 | MCF-7 | breast: | n/a | n/a |
17 | CTCF | chr7:6911507-6911677 | GM12892 | blood: | n/a | n/a |
18 | CTCF | chr7:6911533-6911668 | GM12891 | blood: | n/a | n/a |
19 | CTCF | chr7:6911542-6911650 | MCF-7 | breast: | n/a | n/a |
20 | CTCF | chr7:6911400-6911550 | NHEK | skin: | n/a | n/a |
21 | CTCF | chr7:6911501-6911599 | H1-hESC | embryonic stem cell: | n/a | n/a |
22 | CTCF | chr7:6911547-6911638 | GM19239 | blood: | n/a | n/a |
23 | CTCF | chr7:6911534-6911710 | HepG2 | liver: | n/a | n/a |
24 | CTCF | chr7:6911561-6911663 | MCF-7 | breast: | n/a | n/a |
25 | CTCF | chr7:6911496-6911773 | K562 | blood: | n/a | n/a |
26 | CTCF | chr7:6911420-6911570 | HMEC | breast: | n/a | n/a |
27 | CTCF | chr7:6911559-6911712 | K562 | blood: | n/a | n/a |
28 | CTCF | chr7:6911625-6911669 | GM10266 | blood: | n/a | n/a |
29 | CTCF | chr7:6911460-6911610 | GM12871 | blood: | n/a | n/a |
30 | CTCF | chr7:6911538-6911673 | MCF-7 | breast: | n/a | n/a |
31 | FOS | chr7:6911198-6911275 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | FOS | chr7:6911500-6911688 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | FOS | chr7:6911488-6911707 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | FOS | chr7:6911520-6911670 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | FOSL2 | chr7:6911405-6911721 | HepG2 | liver: | n/a | n/a |
36 | FOSL2 | chr7:6913744-6914123 | HepG2 | liver: | n/a | chr7:6913918-6913929 |
37 | FOSL2 | chr7:6913703-6914121 | HepG2 | liver: | n/a | chr7:6913918-6913929 |
38 | FOXA1 | chr7:6911517-6911980 | HepG2 | liver: | n/a | n/a |
39 | FOXA1 | chr7:6913802-6914357 | HepG2 | liver: | n/a | n/a |
40 | HEY1 | chr7:6912130-6912403 | HepG2 | liver: | n/a | n/a |
41 | HNF4A | chr7:6912189-6912428 | HepG2 | liver: | n/a | chr7:6912373-6912388 |
42 | HNF4A | chr7:6912184-6912434 | HepG2 | liver: | n/a | chr7:6912373-6912388 |
43 | HNF4G | chr7:6912199-6912494 | HepG2 | liver: | n/a | chr7:6912372-6912387 |
44 | JUND | chr7:6912215-6912416 | HepG2 | liver: | n/a | n/a |
45 | JUND | chr7:6913826-6914043 | HepG2 | liver: | n/a | n/a |
46 | JUND | chr7:6913870-6913984 | HepG2 | liver: | n/a | n/a |
47 | MAFF | chr7:6922881-6922953 | HepG2 | liver: | n/a | n/a |
48 | MYBL2 | chr7:6912150-6912695 | HepG2 | liver: | n/a | n/a |
49 | MYC | chr7:6911145-6911385 | MCF-7 | breast: | n/a | n/a |
50 | MYC | chr7:6911186-6911288 | MCF-7 | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:6915894-6915944 | NB4 | blood: | n/a |
2 | chr7:6915894-6915944 | NB4 | blood: | n/a |
3 | chr7:6915373-6915423 | PrEC | prostate: | n/a |
4 | chr7:6911051-6911101 | IMR90 | lung: | fetal |
5 | chr7:6915508-6915558 | Hepatocyte | liver: | n/a |
6 | chr7:6911211-6911261 | NT2-D1 | testis: | n/a |
7 | chr7:6914498-6914548 | AoSMC | blood vessel: | n/a |
8 | chr7:6915373-6915423 | HEEpiC | esophagus: | n/a |
9 | chr7:6921561-6921611 | HNPCEpiC | eye: | n/a |
10 | chr7:6914289-6914339 | HRE | kidney: | n/a |
11 | chr7:6915508-6915558 | HRPEpiC | eye: | n/a |
12 | chr7:6911211-6911261 | HIPEpiC | eye: | n/a |
13 | chr7:6915508-6915558 | T-47D | breast: | n/a |
14 | chr7:6915508-6915558 | SK-N-SH | brain: | n/a |
15 | chr7:6916089-6916139 | HMEC | breast: | n/a |
16 | chr7:6916089-6916139 | T-47D | breast: | n/a |
17 | chr7:6915373-6915423 | H1-hESC | embryonic stem cell: | embryo |
18 | chr7:6914498-6914548 | HEK293 | kidney: | embryo |
19 | chr7:6916089-6916139 | ovcar-3 | ovarian: | n/a |
20 | chr7:6914498-6914548 | HCF | heart: | n/a |
21 | chr7:6915894-6915944 | AoSMC | blood vessel: | n/a |
22 | chr7:6915508-6915558 | HUVEC | blood vessel: | n/a |
23 | chr7:6915508-6915558 | GM12878 | blood: | n/a |
24 | chr7:6914289-6914339 | H1-hESC | embryonic stem cell: | embryo |
25 | chr7:6915928-6915978 | H1-hESC | embryonic stem cell: | embryo |
26 | chr7:6921561-6921611 | IMR90 | lung: | fetal |
27 | chr7:6914498-6914548 | MCF-7 | breast: | n/a |
28 | chr7:6915508-6915558 | HMEC | breast: | n/a |
29 | chr7:6915894-6915944 | HCM | heart: | n/a |
30 | chr7:6915928-6915978 | A549 | lung: | n/a |
31 | chr7:6915508-6915558 | HRE | kidney: | n/a |
32 | chr7:6911211-6911261 | LNCaP | prostate: | n/a |
33 | chr7:6915373-6915423 | HCT-116 | colon: | n/a |
34 | chr7:6915508-6915558 | SAEC | small airway: | n/a |
35 | chr7:6915508-6915558 | AG04450 | lung: | fetal |
36 | chr7:6921561-6921611 | BE2_C | brain: | n/a |
37 | chr7:6911211-6911261 | AG04450 | lung: | fetal |
38 | chr7:6921561-6921611 | Hela-S3 | cervix: | n/a |
39 | chr7:6915508-6915558 | HCF | heart: | n/a |
40 | chr7:6914289-6914339 | U87 | brain: | n/a |
41 | chr7:6915373-6915423 | Hela-S3 | cervix: | n/a |
42 | chr7:6915508-6915558 | PANC-1 | pancreas: | n/a |
43 | chr7:6921561-6921611 | U87 | brain: | n/a |
44 | chr7:6915894-6915944 | A549 | lung: | n/a |
45 | chr7:6911051-6911101 | AG04449 | skin: | fetal |
46 | chr7:6911051-6911101 | AG09309 | skin: | n/a |
47 | chr7:6915373-6915423 | HCM | heart: | n/a |
48 | chr7:6914289-6914339 | HAEpiC | amniotic membrane: | n/a |
49 | chr7:6915928-6915978 | NT2-D1 | testis: | n/a |
50 | chr7:6921561-6921611 | PrEC | prostate: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR7E136P | TF binding region |
ENSG00000263457 | TF binding region |
OR7E59P | TF binding region |
OR7E136P | CpG island |
ENSG00000263457 | CpG island |
OR7E59P | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559368962 | chr7:6911027-6911028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs371746433 | chr7:6911039-6911040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs545675296 | chr7:6911042-6911043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188287526 | chr7:6911069-6911070 | Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs34601496 | chr7:6911077-6911078 | Enhancers | TF binding regionCpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs184135335 | chr7:6911080-6911081 | Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs35719605 | chr7:6911082-6911083 | Enhancers | TF binding regionCpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs558804130 | chr7:6911099-6911100 | Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs113805474 | chr7:6911103-6911104 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs181565764 | chr7:6911123-6911124 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs144887884 | chr7:6911125-6911126 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs571615654 | chr7:6911168-6911169 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs538613277 | chr7:6911178-6911179 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs187265134 | chr7:6911193-6911194 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs569821499 | chr7:6911195-6911196 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs151323941 | chr7:6911203-6911204 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs534550601 | chr7:6911206-6911207 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs372143541 | chr7:6911211-6911212 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs574552332 | chr7:6911212-6911213 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs112265207 | chr7:6911219-6911220 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs573908973 | chr7:6911224-6911225 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs541124741 | chr7:6911228-6911229 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs139278849 | chr7:6911230-6911231 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs190458538 | chr7:6911240-6911241 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs557240495 | chr7:6911246-6911247 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs563318855 | chr7:6911248-6911249 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs575499595 | chr7:6911254-6911255 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs10228947 | chr7:6911256-6911257 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs561126819 | chr7:6911261-6911262 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs528710993 | chr7:6911266-6911267 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs372779387 | chr7:6911277-6911278 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs565184444 | chr7:6911279-6911280 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs182542530 | chr7:6911324-6911325 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs550665578 | chr7:6911339-6911340 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs185878070 | chr7:6911342-6911343 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs10275812 | chr7:6911345-6911346 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs549344177 | chr7:6911352-6911353 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs561163539 | chr7:6911365-6911366 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs573173038 | chr7:6911381-6911382 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs145255430 | chr7:6911393-6911394 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs112525329 | chr7:6911410-6911411 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs540402306 | chr7:6911417-6911418 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs567538662 | chr7:6911443-6911444 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs141283172 | chr7:6911448-6911449 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs111906123 | chr7:6911449-6911450 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs182631573 | chr7:6911503-6911504 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs185731914 | chr7:6911504-6911505 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs542913500 | chr7:6911516-6911517 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs111396544 | chr7:6911538-6911539 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs146713320 | chr7:6911550-6911551 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lynch syndrome | 22585707 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Breast cancer | 16397240 | CNVD |
Raine Syndrome | 17924334 | CNVD |
Diffuse large b-cell lymphoma | 21266526 | CNVD |
Melanoma | 18172304 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Glioma | 18556773 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 21045282 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:6910800-6911200 | Enhancers | Stomach Mucosa | stomach |
2 | chr7:6910800-6911200 | Enhancers | NHEK | skin |
3 | chr7:6910800-6911600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr7:6910800-6914000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr7:6911200-6912400 | Weak transcription | Stomach Mucosa | stomach |
6 | chr7:6911400-6913600 | Enhancers | Fetal Intestine Small | intestine |
7 | chr7:6911800-6913000 | Enhancers | HepG2 | liver |
8 | chr7:6912400-6912800 | Enhancers | Fetal Intestine Large | intestine |
9 | chr7:6912400-6912800 | Enhancers | Stomach Mucosa | stomach |
10 | chr7:6913000-6913600 | Weak transcription | HepG2 | liver |
11 | chr7:6913400-6913800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
12 | chr7:6913400-6914400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr7:6913600-6913800 | Enhancers | HepG2 | liver |
14 | chr7:6913600-6914800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr7:6914000-6914400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr7:6914400-6915000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr7:6921000-6923000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr7:6921400-6922600 | Enhancers | NH-A | brain |
19 | chr7:6921400-6922800 | Enhancers | HSMM | muscle |
20 | chr7:6921400-6923000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
21 | chr7:6921600-6922200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
22 | chr7:6921600-6923000 | Enhancers | HSMMtube | muscle |
23 | chr7:6922000-6922200 | Enhancers | Osteobl | bone |
24 | chr7:6922200-6922600 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
25 | chr7:6922200-6922600 | Flanking Active TSS | Osteobl | bone |
26 | chr7:6922600-6922800 | Enhancers | Osteobl | bone |
27 | chr7:6922600-6927600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
28 | chr7:6923000-6927800 | Weak transcription | HSMMtube | muscle |